Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulla K Griffiths

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Plos One|July 5, 2013
Assessment of health benefits and cost-effectiveness of 10-valent and 13-valent pneumococcal conjugate vaccination in Kenyan childrenPhilip Ayieko, Ulla K Griffiths, Moses Ndiritu, et al.
Paediatrics and International Child Health|May 19, 2012
Economic burden of acute lower respiratory tract infection in South African childrenAnushua Sinha, Soyeon Kim, Gary Ginsberg, et al.
The Journal of Pediatrics|June 19, 2013
Impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccination in IndiaAndrew D Clark, Ulla K Griffiths, Syed Shahid Abbas, et al.
Vaccine|July 4, 2006
Costs of congenital rubella syndrome (CRS) in Oman: evidence based on long-term follow-up of 43 childrenSalah Al-Awaidy, Ulla K Griffiths, Hosammudin Mohammed Nwar, et al.
The Pediatric Infectious Disease Journal|April 10, 2008
Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in IndonesiaBradford D Gessner, Endang R Sedyaningsih, Ulla K Griffiths, et al.
BMC Public Health|August 21, 2016
Social mobilisation, consent and acceptability: a review of human papillomavirus vaccination procedures in low and middle-income countriesSeverin Kabakama, Katherine E Gallagher, Natasha Howard, et al.
Plos One|June 3, 2017
Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countriesKatherine E Gallagher, Natasha Howard, Severin Kabakama, et al.
African Health Sciences|March 10, 2016
New pneumococcal conjugate vaccine introductions in four sub-Saharan African countries: a cross-country analysis of health systems' impactsSergio Torres-Rueda, Helen Ed Burchett, Ulla K Griffiths, et al.
Vaccine|August 10, 2010
Global use of Haemophilus influenzae type b conjugate vaccineLinda R Ojo, Rosalyn E O'Loughlin, Adam L Cohen, et al.
Vaccine|September 28, 2014
The impact of introducing new vaccines on the health system: case studies from six low- and middle-income countriesHelen E D Burchett, Sandra Mounier-Jack, Sergio Torres-Rueda, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Plos One|July 5, 2013
Assessment of health benefits and cost-effectiveness of 10-valent and 13-valent pneumococcal conjugate vaccination in Kenyan childrenPhilip Ayieko, Ulla K Griffiths, Moses Ndiritu, et al.
Paediatrics and International Child Health|May 19, 2012
Economic burden of acute lower respiratory tract infection in South African childrenAnushua Sinha, Soyeon Kim, Gary Ginsberg, et al.
The Journal of Pediatrics|June 19, 2013
Impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccination in IndiaAndrew D Clark, Ulla K Griffiths, Syed Shahid Abbas, et al.
Vaccine|July 4, 2006
Costs of congenital rubella syndrome (CRS) in Oman: evidence based on long-term follow-up of 43 childrenSalah Al-Awaidy, Ulla K Griffiths, Hosammudin Mohammed Nwar, et al.
The Pediatric Infectious Disease Journal|April 10, 2008
Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in IndonesiaBradford D Gessner, Endang R Sedyaningsih, Ulla K Griffiths, et al.
BMC Public Health|August 21, 2016
Social mobilisation, consent and acceptability: a review of human papillomavirus vaccination procedures in low and middle-income countriesSeverin Kabakama, Katherine E Gallagher, Natasha Howard, et al.
Plos One|June 3, 2017
Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countriesKatherine E Gallagher, Natasha Howard, Severin Kabakama, et al.
African Health Sciences|March 10, 2016
New pneumococcal conjugate vaccine introductions in four sub-Saharan African countries: a cross-country analysis of health systems' impactsSergio Torres-Rueda, Helen Ed Burchett, Ulla K Griffiths, et al.
Vaccine|August 10, 2010
Global use of Haemophilus influenzae type b conjugate vaccineLinda R Ojo, Rosalyn E O'Loughlin, Adam L Cohen, et al.
Vaccine|September 28, 2014
The impact of introducing new vaccines on the health system: case studies from six low- and middle-income countriesHelen E D Burchett, Sandra Mounier-Jack, Sergio Torres-Rueda, et al.
Pageof 5